Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012 Jun 13:3:204.
doi: 10.3389/fphys.2012.00204. eCollection 2012.

Controlling Parasympathetic Regulation of Heart Rate: A Gatekeeper Role for RGS Proteins in the Sinoatrial Node

Alexandra S Mighiu  1 , Scott P Heximer
Affiliations

Controlling Parasympathetic Regulation of Heart Rate: A Gatekeeper Role for RGS Proteins in the Sinoatrial Node

Alexandra S Mighiu et al. Front Physiol. .

Abstract

Neurotransmitters released from sympathetic and parasympathetic nerve terminals in the sinoatrial node (SAN) exert their effects via G-protein-coupled receptors. Integration of these different G-protein signals within pacemaker cells of the SAN is critical for proper regulation of heart rate and function. For example, excessive parasympathetic signaling can be associated with sinus node dysfunction (SND) and supraventricular arrhythmias. Our previous work has shown that one member of the regulator of G-protein signaling (RGS) protein family, RGS4, is highly and selectively expressed in pacemaker cells of the SAN. Consistent with its role as an inhibitor of parasympathetic signaling, RGS4-knockout mice have reduced basal heart rates and enhanced negative chronotropic responses to parasympathetic agonists. Moreover, RGS4 appears to be an important part of SA nodal myocyte signaling pathways that mediate G-protein-coupled inwardly rectifying potassium channel (GIRK) channel activation/deactivation and desensitization. Since RGS4 acts immediately downstream of M2 muscarinic receptors, it is tempting to speculate that RGS4 functions as a master regulator of parasympathetic signaling upstream of GIRKs, HCNs, and L-type Ca(2+) channels in the SAN. Thus, loss of RGS4 function may lead to increased susceptibility to conditions associated with increased parasympathetic signaling, including bradyarrhythmia, SND, and atrial fibrillation.

Keywords: GIRK channels; RGS protein; bradyarrhythmia; parasympathetic signaling; sinoatrial node.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Modeling parasympathetic signaling pathways in pacemaker cells of the SAN in the presence (A) and absence (B) of RGS4 function. Note the potential for RGS4 to act as a master upstream regulator of the primary effectors of the M2 muscarinic receptor (GIRK channels, and adenylyl cyclase). (A) In the model where RGS4 is functional, Gαi signaling is attenuated resulting in decreased GIRK channel activity and increased cAMP concentrations that can directly stimulate increased HCN4 channel activity and indirectly (via PKA activation) increases CaV channel activity. (B) In the model where RGS4 function is absent Gαi signaling is increased resulting in increased GIRK channel activity and decreased cAMP concentrations. This condition is expected to result in lower HCN4 and CaV channel activity.
See this image and copyright information in PMC

References

    1. Aistrup G. L., Cokic I., Ng J., Gordon D., Koduri H., Browne S., Arapi D., Segon Y., Goldstein J., Angulo A., Wasserstrom J. A., Goldberger J. J., Kadish A. H., Arora R. (2011). Targeted nonviral gene-based inhibition of Galpha(i/o)-mediated vagal signaling in the posterior left atrium decreases vagal-induced atrial fibrillation. Heart Rhythm 8, 1722–172910.1016/j.hrthm.2011.06.012 - DOI - PMC - PubMed
    1. Aistrup G. L., Villuendas R., Ng J., Gilchrist A., Lynch T. W., Gordon D., Cokic I., Mottl S., Zhou R., Dean D. A., Wasserstrom J. A., Goldberger J. J., Kadish A. H., Arora R. (2009). Targeted G-protein inhibition as a novel approach to decrease vagal atrial fibrillation by selective parasympathetic attenuation. Cardiovasc. Res. 83, 481–49210.1093/cvr/cvp148 - DOI - PMC - PubMed
    1. Benditt D. G., Sakaguchi S., Goldstein M. A., Lurie K. G., Gornick C. C., Adler S. W. (1995). “Sinus node dysfunction: pathophysiology, clinical features, evaluation, and treatment,” in Cardiac Electrophysiology: From Cell to Bedside, 2nd Edn, eds Zipes D. P., Jalife J. (Philadelphia, PA: WB Saunders Company; ), 1215–1247
    1. Benson D. W., Wang D. W., Dyment M., Knilans T. K., Fish F. A., Strieper M. J., Rhodes T. H., George A. L., Jr. (2003). Congenital sick sinus syndrome caused by recessive mutations in the cardiac sodium channel gene (SCN5A). J. Clin. Invest. 112, 1019–102810.1172/JCI200318062 - DOI - PMC - PubMed
    1. Berman D. M., Wilkie T. M., Gilman A. G. (1996). GAIP and RGS4 are GTPase-activating proteins for the Gi subfamily of G protein alpha subunits. Cell 86, 445–45210.1016/S0092-8674(00)80117-8 - DOI - PubMed